ClinicalTrials.Veeva
Menu

Find clinical trials for Ovarian Cancer in Seattle, WA

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Ovarian Epithelial Carcinoma
Cancer
Carcinoma
Endometrial Cancer
Fallopian Tube Cancer
Breast Cancer
Triple Negative Breast Cancer

Ovarian Cancer trials near Seattle, WA, USA:

A Trial of Vigil for Participants With Ovarian Cancer (VITAL)

The goal of this clinical trial is to compare participants with ovarian, fallopian tube or primary peritoneal cancer when treated w...

Active, not recruiting
Ovarian Neoplasms
Ovarian Cancer
Biological: Vigil
Other: Placebo

Phase 2

Gradalis

Tacoma, Washington, United States and 25 other locations

(CAR) T cells developed by Precigen, Inc.) in treating patients with ovarian, fallopian tube, or primary peritoneal cancer that has...

Enrolling
Stage IIIC Ovarian Cancer AJCC v8
Stage IIIA Ovarian Cancer AJCC v8
Biological: PRGN-3005 UltraCAR-T cells

Phase 1

Precigen

Seattle, Washington, United States and 1 other location

This is a multi-center, open-label phase 1 dose escalation trial that uses a modified 3+3 design to identify a recommended phase 2 dose (RP2D) of AB-...

Enrolling
Ovarian Neoplasms
Carcinoma, Ovarian Epithelial
Biological: AB-1015

Phase 1

ArsenalBio

Seattle, Washington, United States and 9 other locations

of 2X-121 as single agent therapy in a 28-days cycle in advanced ovarian cancer patients. 2X-121 will be supplied for oral administ...

Active, not recruiting
Advanced Ovarian Cancer
Drug: 2X-121
Device: 2X-121 DRP®

Phase 2

Allarity Therapeutics

Seattle, Washington, United States and 4 other locations

within each cohort-specific supplement in participants with ovarian, fallopian tube, or primary peritoneal cancer. Cohort A (single ...

Enrolling
Ovarian Neoplasms
Drug: Niraparib
Drug: Paclitaxel

Phase 1, Phase 2

Tesaro
Tesaro

Seattle, Washington, United States and 24 other locations

outcome of ADP A2M4CD8 as monotherapy and in combination treatment with nivolumab in human leukocyte antigen (HLA) A2+ subjects with recurrent ovarian...

Enrolling
Ovarian Cancer
Genetic: Autologous genetically modified ADP-A2M4CD8 cells
Combination Product: Autologous genetically modified ADP-A2M4CD8 cells in combination with Nivolumab

Phase 2

Adaptimmune

Seattle, Washington, United States and 27 other locations

as maintenance therapy in participants with platinum-sensitive ovarian, primary peritoneal or fallopian tube cancers with high fola...

Enrolling
Peritoneal Cancer
Fallopian Tube Cancer
Drug: Bevacizumab
Drug: Mirvetuximab soravtansine plus Bevacizumab

Phase 3

ImmunoGen
ImmunoGen

Seattle, Washington, United States and 151 other locations

maintenance treatment in participants with advanced (stage IIIB-IV) ovarian cancer, fallopian tube cancer, or primary peri...

Active, not recruiting
Ovarian Neoplasms
Biological: Bevacizumab
Drug: Niraparib

Phase 2

Tesaro
Tesaro

Seattle, Washington, United States and 27 other locations

Ovarian cancer is a heterogeneous disease, characterized by complex molecular and genetic changes. The high expression of vascular ...

Active, not recruiting
Ovarian Neoplasms
Ovarian, Fallopian Tube and Primary Peritoneal Carcinoma
Drug: Niraparib
Drug: Standard of care

Phase 3

Tesaro
Tesaro

Seattle, Washington, United States and 189 other locations

of sovilnesib at different dose levels to establish the Recommended Phase 2 Dose (RP2D) of sovilnesib in subjects with high grade serous ovarian...

Enrolling
Fallopian Tube Cancer
Primary Peritoneal Carcinoma
Drug: Sovilnesib

Phase 1

Volastra Therapeutics

Seattle, Washington, United States and 2 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems